Newsbenzinga
Phio Pharmaceuticals Expects FDA Response On PH-762 Phase 2b Plan By End Of November; Sees Phase 2b Start In Q1 2027; Q3 Ending Cash $10.6M
· Published
Article summary
Please check the source for details.
An excerpt from the original article.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…